Abstract
BackgroundThe study objectives were to transition in-person colorectal cancer multidisciplinary clinic (MDC) to a telehealth MDC (tele-MDC) format and to assess early outcomes. MethodsA colorectal tele-MDC was devised, in which patients used remote-access technology while supervised by a clinician. The team consisted of surgeons, medical oncologists, radiation oncologists, radiologists, and pathologists. Outcomes were assessed with patient and provider surveys, using a 5-point Likert scale (higher = more favorable).ResultsA total of 18 patients participated in the tele-MDC. Surveyed patients (n=18) and physicians (n=19) were satisfied with the quality of care (mean Likert = 4.93, 4.53, respectively), and low standard deviations (range 0-1.03) across all questions reflected homogeneity in satisfaction with the metrics surveyed.ConclusionsThis pilot study demonstrates that a functional colorectal cancer tele-MDC is a feasible alternative to in-person MDC during the coronavirus disease 2019 (COVID-19) pandemic, with the potential for a high degree of patient and physician satisfaction.
Highlights
For a patient with a new diagnosis of rectal cancer, navigating the modern healthcare system through all of the required appointments can be an overwhelming task
A total of 18 patients participated in the tele-multidisciplinary clinic (MDC)
Surveyed patients (n=18) and physicians (n=19) were satisfied with the quality of care, and low standard deviations across all questions reflected homogeneity in satisfaction with the metrics surveyed. This pilot study demonstrates that a functional colorectal cancer tele-MDC is a feasible alternative to inperson MDC during the coronavirus disease 2019 (COVID-19) pandemic, with the potential for a high degree of patient and physician satisfaction
Summary
A colorectal tele-MDC was devised, in which patients used remote-access technology while supervised by a clinician.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have